4.7 Review

NAD+ metabolism and its roles in cellular processes during ageing

期刊

NATURE REVIEWS MOLECULAR CELL BIOLOGY
卷 22, 期 2, 页码 119-141

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41580-020-00313-x

关键词

-

资金

  1. NIH [R24DK085610]
  2. Buck Institute for Research on Aging intramural funds
  3. University of California President's Postdoctoral Fellowship at the University of California, San Francisco
  4. NIH T32 training grant [3T32AG000266-19S1]

向作者/读者索取更多资源

NAD(+) is a crucial coenzyme in redox reactions and plays a pivotal role in energy metabolism. Its levels decline with age, and raising NAD(+) levels is being explored as a potential strategy to extend human lifespan and healthspan. NAD(+) influences key cellular processes and functions, including metabolic pathways, DNA repair, and cellular senescence, with implications for healthy aging and age-related diseases.
Nicotinamide adenine dinucleotide (NAD(+)) is a central redox factor and enzymatic cofactor that functions in a plethora of cellular processes, including metabolic pathways and DNA metabolism, and affects cell fate and function. NAD(+) levels gradually decline with age, and therapeutic elevation of NAD(+) levels is being trialled for extending human healthspan and lifespan. Nicotinamide adenine dinucleotide (NAD(+)) is a coenzyme for redox reactions, making it central to energy metabolism. NAD(+) is also an essential cofactor for non-redox NAD(+)-dependent enzymes, including sirtuins, CD38 and poly(ADP-ribose) polymerases. NAD(+) can directly and indirectly influence many key cellular functions, including metabolic pathways, DNA repair, chromatin remodelling, cellular senescence and immune cell function. These cellular processes and functions are critical for maintaining tissue and metabolic homeostasis and for healthy ageing. Remarkably, ageing is accompanied by a gradual decline in tissue and cellular NAD(+) levels in multiple model organisms, including rodents and humans. This decline in NAD(+) levels is linked causally to numerous ageing-associated diseases, including cognitive decline, cancer, metabolic disease, sarcopenia and frailty. Many of these ageing-associated diseases can be slowed down and even reversed by restoring NAD(+) levels. Therefore, targeting NAD(+) metabolism has emerged as a potential therapeutic approach to ameliorate ageing-related disease, and extend the human healthspan and lifespan. However, much remains to be learnt about how NAD(+) influences human health and ageing biology. This includes a deeper understanding of the molecular mechanisms that regulate NAD(+) levels, how to effectively restore NAD(+) levels during ageing, whether doing so is safe and whether NAD(+) repletion will have beneficial effects in ageing humans.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据